Exelixis Highlights $2.4B 2026 Outlook, Cabometyx Momentum and Zanzalintinib Catalysts at Conference

Exelixis (NASDAQ:EXEL) detailed its commercial momentum for cabozantinib and outlined key upcoming clinical catalysts for ...

Exelixis Highlights CABOMETYX Growth, Zanzalintinib PDUFA and Pipeline Strategy at Barclays Conference

Exelixis (NASDAQ:EXEL) described its current commercial trajectory, late-stage clinical programs, and strategic priorities ...

Marathon's ranked mode homework explains holotags, score targets, and penalties

Bungie's "Ranked Calculation Worksheet" is a one-page homework assignment. Copy our work to learn more about Marathon's ...

Mkango Resources Limited Announces Feasibility Study: Songwe & PFS Results: PUŁAWY

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA AND THE UNITED KINGDOM ONLY AND IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND ...
Razzball

RCL Update: RCL ADPs 2026

A look at early draft ADPs for the Razzball Commenter Leagues as well as how to join for 2026 fantasy baseball.